Melanoma: open trials in China

69 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07492680
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
Beijing · Chongqing University Cancer Hospital, Chongqing · Guangzhou · Shanghai GoBroad Cancer Hospital China Pharmaceutical University, Shanghai · Fudan University Shanghai Cancer Center, Shanghai · The First Affiliated Hospital of Henan Medical University, Xinxiang
Registry updated 2026-11-04
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Beijing
Registry updated 2026-11-03
NCT06739226
Combination Immunotherapy Targeting Melanoma
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-10-30
NCT06953089
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 2 · DualityBio Inc.
CHN23-0, Beijing · CHN02-0, Beijing · CHN13-0, Beijing · CHN11-0, Changsha · CHN24-0, Chengdu · CHN17-0, Dongguan · CHN06-0, Henan · CHN04-0, Hubei · CHN01-0, Shanghai · CHN04-0, Shanghai · CHN35-0, Shenyang · CHN34-0, Wuhan · CHN26-0, Wuhan · CHN25-0, Xi'an · CHN12-0, Xinxiang · CHN16-0, Xuzhou
Registry updated 2026-10-29
NCT07841925
A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors
Trial Treatment · Phase 1/2 · Sichuan Baili Pharmaceutical Co., Ltd.
Beijing Cancer Hospital, Beijing
Registry updated 2026-10-29
NCT07406724
HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma（FASTIL-Mela02）
Trial Treatment · Phase 2 · Hangzhou Huasai Biomedicine Co., Ltd.
Beijing Cancer Hospital, Beijing
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
West China Hospital，Sichuan University, Chengdu · Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2026-10-26
NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · DualityBio Inc.
Baoding · Beijing · Beijing · Beijing · Changchun · Changchun · Changsha · Changsha · Chengdu · Chengdu · Chengdu · Chengdu · Chongqing · Chongqing · Chongqing · Chongqing · Fuzhou · Ganzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Hangzhou · Hangzhou · Hangzhou · Hangzhou · Hangzhou · Harbin · Hefei · Jinan · Jinan · Linyi · Linyi · Luoyang · Nanchang · Nanchang · Nanjing · Nanjing · Nanjing · Nanning · Shanghai · Shanghai · Shanghai · Shenyang · Shenyang · Taizhou · Tianjin · Tianjin · Tianjin · Wuhan · Wuhan · Xi’an · Xinxiang · Zhengzhou · Zhengzhou
Registry updated 2026-10-21
NCT07099430
A Trial of LBL-024 Monotherapy or Combination With Toripalimab in Patients With Advanced Melanoma.
Trial Treatment · Phase 1/2 · Nanjing Leads Biolabs Co.,Ltd
Beijing GoBroad Hospital, Beijing · The First Hospital of Jilin University, Changchun · West China Hospital of Sichuan University, Chengdu · Fujian Cancer Hospital, Fuzhou · Dermatology Hospital of Southern Medical University, Guangzhou · Sun Yat-sen University Cancer Center, Guangzhou · Zhejiang Cancer Hospital, Hangzhou · Shandong Cancer Hospital, Jinan · Yunnan Cancer Hospital, Kunming · Nanjing Drum Tower hospital, Nanjing · Guangxi Medical University Cancer Hospital, Nanning · Fudan University Shanghai Cancer Center, Shanghai · Shanxi Bethune Hospital, Taiyuan · Tianjin Medical University Cancer Institute & Hospital, Tianjin · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Registry updated 2026-10-21
NCT07760012
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
Trial Treatment · Peking University Third Hospital
Peking University Third Hospital, Beijing
Registry updated 2026-10-15
NCT06596915
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
Trial Treatment · Phase 1 · Shandong Boan Biotechnology Co., Ltd
Beijing Cancer Hospital, Beijing
Registry updated 2026-10-13
NCT07070232
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Trial Treatment · Phase 1/2 · BioNTech SE
Chongqing University Cancer Hospital, Chongqing · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · Tianjin Medical University Cancer Institute & Hospital, Tianjin · Hubei Cancer Hospital, Wuhan
Registry updated 2026-10-09
NCT07847359
Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial
Trial Treatment · Phase 2 · Sun Yat-sen University
Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2026-09-29
NCT07848243
Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
Trial Treatment · Phase 2 · Peking University Cancer Hospital & Institute
Beijing Cancer Hospital, Beijing
Registry updated 2026-09-29
NCT07177937
A Study of DXC014 in Patients With Advanced Solid Tumors.
Trial Treatment · Phase 1 · Hangzhou DAC Biotechnology Co., Ltd.
Peking University First Hospital, Beijing · Hunan Cancer Hospital, Changsha · Zhejiang Cancer Hospital, Hangzhou · The First Affiliated Hospital of NanChang University, Nanchang · The Affiliated Hospital of Qingdao University, Qingdao
Registry updated 2026-09-23
NCT07562841
Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
Trial Treatment · Phase 1 · West China Hospital
West China Hospital，Sichuan University, Chengdu
Registry updated 2026-09-21
NCT07400302
Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
Trial Treatment · Phase 2 · The First Hospital of Jilin University
The First Hospital of Jilin University, Changchun
Registry updated 2026-09-03
NCT04913285
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Trial Treatment · Phase 1 · Pierre Fabre Medicament
Beijing University Cancer Hospital, Beijing · Harbin Medical University Cancer Hospital, Haerbin · LinYi Cancer Hospital, Linyi · The Shanghai Pulmonary Hospital, Shanghai
Registry updated 2026-09-02
NCT07310784
A Phase II Trial of LM103 in Advanced Melanoma
Trial Treatment · Phase 2 · Suzhou BlueHorse Therapeutics Co., Ltd.
Beijing Go Broad Hospital, Beijing · Beijing Cancer Hospital, Beijing · The First Hospital of Jilin University, Changchun · Jilin Cancer Hospital, Changchun · West China Hospital of Sichuan University, Chengdu · Fujian Cancer Hospital, Fuzhou · Sun Yat-sen University Cancer Center, Guangzhou · Zhejiang Cancer Hospital, Hangzhou · Nanjing Drum Tower hospital, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · Guangxi Medical University Cancer Hospital, Nanning · Fudan University Shanghai Cancer Center, Shanghai · Tianjin Medical University Cancer Institute & Hospital, Tianjin · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The Third People's Hospital of Zhengzhou, Zhengzhou
Registry updated 2026-08-31
NCT07280832
Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors
Trial Treatment · Phase 1/2 · Shanghai JMT-Bio Inc.
BeiJing Cancer Hospital EC, Beijing
Registry updated 2026-08-18
NCT07750067
Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
Trial Treatment · Phase 2 · Sun Yat-sen University
Sun Yat-sen University, Guangzhou
Registry updated 2026-08-10
NCT06214156
A Clinical Study of T3011 in Subjects With Advanced Melanoma
Trial Treatment · Phase 1/2 · Shanghai Pharmaceuticals Holding Co., Ltd
Beijing Cancer Hospital, Beijing · The First Affiliated Hospital of Bengbu Medical College, Bengbu · Jilin Cancer Hospital, Changchun · Chengdu Shangjin Nanfu Hospital, Chengdu · Fujian Cancer Hospital, Fuzhou · The Third People's Hospital of Zhengzhou, Zhengzhou · Sun Yat-sen University Cancer Center, Zhongshan
Registry updated 2026-08-06
NCT06703398
A Study of GC101 TIL in Advanced Melanoma
Trial Treatment · Phase 2 · Shanghai Juncell Therapeutics
Beijing Cancer Hospital, Beijing
Registry updated 2026-08-05
NCT06081920
A Study of IBI363 in Subjects With Advanced Melanoma
Trial Treatment · Phase 2 · Innovent Biologics (Suzhou) Co. Ltd.
Peking University Cancer Hospital & Institute, Beijing, China,, Beijing · Beijing Cancer Hospital, Beijing · The First Hospital of Jilin University, Changchun · Jilin Cancer Hospital, Changchun · Hunan Cancer Hospital, Changsha · Fujian Cancer Hospital, Fuzhou · Qilu Hospital of Shandong University, Jinan · Yunan Cancer Hospital, Kunming · The First Affiliated Hospital of NanChang University, Nanchang · Nanjing Drum Tower hospital, Nanjing · Shanxi Bethune Hospital, Taiyuan · The Third People's Hospital of Zhengzhou, Zhengzhou
Registry updated 2026-07-29
NCT07518043
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Trial Treatment · Phase 1 · Shanghai Henlius Biotech
Fujian Medical University Union Hospital, Fuzhou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · The Second Hospital of Tianjin Medical University, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Registry updated 2026-07-27

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error